Marshall Wace’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-68,109
| Closed | -$765K | – | 3188 |
|
|
2025
Q4 | $765K | Buy |
+68,109
| New | +$779K | ﹤0.01% | 2062 |
|
|
2025
Q2 | – | Sell |
-39,341
| Closed | -$564K | – | 2697 |
|
|
2025
Q1 | $564K | Sell |
39,341
-25,424
| -39% | -$397K | ﹤0.01% | 2031 |
|
|
2024
Q4 | $1.03M | Buy |
+64,765
| New | +$1.28M | ﹤0.01% | 1721 |
|
|
2023
Q3 | – | Sell |
-20,100
| Closed | -$514K | – | 2181 |
|
|
2023
Q2 | $514K | Sell |
20,100
-2,200
| -10% | -$57.9K | ﹤0.01% | 1970 |
|
|
2023
Q1 | $663K | Buy |
+22,300
| New | +$647K | ﹤0.01% | 1988 |
|
|
2022
Q2 | – | Sell |
-253,525
| Closed | -$8.49M | – | 3405 |
|
|
2022
Q1 | $8.49M | Buy |
253,525
+220,924
| +678% | +$7.11M | 0.02% | 988 |
|
|
2021
Q4 | $1.13M | Buy |
32,601
+1,160
| +4% | +$37.5K | ﹤0.01% | 2417 |
|
|
2021
Q3 | $981K | Buy |
+31,441
| New | +$1.07M | ﹤0.01% | 2030 |
|
|
2021
Q2 | – | Sell |
-48,785
| Closed | -$2.13M | – | 2638 |
|
|
2021
Q1 | $2.13M | Buy |
+48,785
| New | +$2.29M | 0.01% | 1297 |
|
|
2020
Q4 | – | Sell |
-57,024
| Closed | -$1.89M | – | 1869 |
|
|
2020
Q3 | $1.89M | Sell |
57,024
-79,448
| -58% | -$2.54M | 0.01% | 825 |
|
|
2020
Q2 | $4.01M | Buy |
136,472
+65,278
| +92% | +$1.89M | 0.03% | 550 |
|
|
2020
Q1 | $1.92M | Buy |
+71,194
| New | +$2.13M | 0.02% | 646 |
|
|
2019
Q4 | – | Sell |
-33,280
| Closed | -$1.25M | – | 1685 |
|
|
2019
Q3 | $1.25M | Sell |
33,280
-137,784
| -81% | -$5.26M | 0.01% | 885 |
|
|
2019
Q2 | $7.46M | Buy |
171,064
+126,969
| +288% | +$5.43M | 0.06% | 367 |
|
|
2019
Q1 | $1.88M | Sell |
44,095
-111,742
| -72% | -$5M | 0.02% | 757 |
|
|
2018
Q4 | $6.98M | Buy |
155,837
+81,786
| +110% | +$4.28M | 0.07% | 348 |
|
|
2018
Q3 | $5.07M | Buy |
+74,051
| New | +$4.77M | 0.04% | 455 |
|
|
2015
Q4 | – | Sell |
-25,699
| Closed | -$731K | – | 968 |
|
|
2015
Q3 | $731K | Sell |
25,699
-1,097
| -4% | -$38.3K | 0.01% | 673 |
|
|
2015
Q2 | $1.08M | Hold |
26,796
| – | – | 0.01% | 590 |
|
|
2015
Q1 | $1.32M | Sell |
26,796
-241,157
| -90% | -$11.2M | 0.02% | 532 |
|
|
2014
Q4 | $12.2M | Buy |
+267,953
| New | +$10.5M | 0.16% | 164 |
|
Other funds holding AVNS
AC
VCM
VPM
Marshall Wace's AVNS Position: Q1 2026 in Review
Marshall Wace sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 68,109 shares — an estimated $765K sold.
Marshall Wace first reported a position in AVNS in Q4 2014 and held it in 21 quarters. The position peaked at $12.2M in Q4 2014. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.
- Marshall Wace reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
- Marshall Wace sold 68,109 Avanos Medical shares in Q1 2026, an estimated $765K.
- Marshall Wace first reported a position in Avanos Medical in Q4 2014 and held it in 21 quarters.
- Marshall Wace's Avanos Medical position peaked at $12.2M in Q4 2014.
- 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.